V-Wave
Matt Borenzweig serves as the Executive Vice President at V-Wave since November 2019 and is the Founder of MB Medical Device Consulting, also established in July 2019, where expertise is focused on advising clients on commercial and operational excellence in the medical device sector. Prior roles include Divisional Vice President at Abbott overseeing U.S. Sales and Marketing for Structural Heart, VP of Sales at Edwards Lifesciences, and Senior VP Sales & Marketing at CardioMEMS, Inc. Matt's extensive career in the cardiovascular field is complemented by experience across various other medical device companies, starting as a Sales Rep at The Upjohn Company in 1985 and progressing through numerous leadership positions. Educational credentials include a BS in Biology/Biological Sciences from USC.
This person is not in any offices
V-Wave
V-Wave Ltd. is a privately held company with offices in Israel and the US. The company is focused on developing percutaneous implantable devices for treating patients with Chronic Heart Failure (HF). V-Wave’s vision is to help patients who remain with disabling symptoms or need hospitalization despite optimized medical treatment. V-Wave hasdeveloped a proprietary interatrial shunt intended to relieve symptoms, reduce hospitalization, increase exercise capacity and improve the overall quality of life.The original concept and development started in Israel with a talented team of engineers and medical scientists. The company’s senior management has decades of experience successfully developing, clinically testing and bringing to market multiple implantable cardiovascular devices.